Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

To identify patents near to expiry

— Pharmaceutical company patent reviewer, Pakistan

To obtain a list of all currently off-patent approved small molecule therapeutics or those that will come off patent in the next 5 years

— Licensing / business development, Saudi Arabia

For information on patent expirations

— Business development manager, Greece

To identify patent expiration dates

— Medicine sourcing, Malaysia

To know the expiration dates of patents

— Regulatory affairs services, Brazil

Generated: May 23, 2017

DrugPatentWatch Database Preview

Doxepin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for doxepin hydrochloride and what is the scope of doxepin hydrochloride patent protection?

Doxepin hydrochloride is the generic ingredient in four branded drugs marketed by Sun Pharm Inds, Par Pharm, Purepac Pharm, Teva Pharms, Pfizer, Wockhardt, Silarx, Pharm Assoc, Sandoz, Watson Labs, Mylan Pharms Inc, Quantum Pharmics, Pernix Theraps Llc, Actavis Elizabeth, Dava Pharms Inc, and New River, and is included in fifty-nine NDAs. There are eight patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Doxepin hydrochloride has fifteen patent family members in four countries.

There are seven drug master file entries for doxepin hydrochloride. Twenty-nine suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: doxepin hydrochloride

Tradenames:4
Patents:8
Applicants:16
NDAs:59
Drug Master File Entries: see list7
Suppliers / Packagers: see list29
Bulk Api Vendors: see list42
Clinical Trials: see list989
Patent Applications: see list908
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxepin hydrochloride at DailyMed

Pharmacology for Ingredient: doxepin hydrochloride

Drug ClassTricyclic Antidepressant

Tentative approvals for DOXEPIN HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe3MGTABLET; ORAL
► Subscribe► Subscribe6MGTABLET; ORAL
► Subscribe► Subscribe6MGTABLET; ORAL
ADD ALERT
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL071669-001Nov 9, 1987RXNoYes► Subscribe► Subscribe
Purepac Pharm
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL073055-001Dec 28, 1990DISCNNoNo► Subscribe► Subscribe
Watson Labs
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL071763-001Feb 9, 1988DISCNNoNo► Subscribe► Subscribe
Dava Pharms Inc
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CAPSULE;ORAL071676-001Jan 5, 1988DISCNNoNo► Subscribe► Subscribe
Pharm Assoc
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
CONCENTRATE;ORAL075924-001Jan 15, 2004DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To obtain lists of generic manufactures, distributors, etc. who can supply (in U.S.) drugs

— Pharmaceutical R&D, USA

To know which brands are on and off patent

— Advertising sales pharma companies, USA

To identify drugs going off patent next year

— Pharmaceutical ingredient manufacturer, India

To be able to inform my clients with Part D prescription plans when a brand name drug is going off patent

— Pharmacist, USA

Want to know data of final approval and tentative approval of drugs launched in the US market

— Pharmaceutical executive, USA

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot